Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 07, 2019

SELL
$123.7 - $156.3 $359,348 - $454,051
-2,905 Closed
0 $0
Q4 2018

Feb 04, 2019

SELL
$120.82 - $174.09 $114,174 - $164,515
-945 Reduced 24.55%
2,905 $367,000
Q3 2018

Nov 20, 2018

SELL
$167.67 - $188.27 $156,771 - $176,032
-935 Reduced 19.54%
3,850 $669,000
Q2 2018

Aug 10, 2018

SELL
$160.33 - $189.41 $90,586 - $107,016
-565 Reduced 10.56%
4,785 $859,000
Q1 2018

May 11, 2018

SELL
$161.53 - $178.11 $21,806 - $24,044
-135 Reduced 2.46%
5,350 $865,000
Q4 2017

Feb 13, 2018

SELL
$147.99 - $163.95 $118,392 - $131,160
-800 Reduced 12.73%
5,485 $875,000
Q3 2017

Nov 07, 2017

SELL
$149.47 - $160.56 $32,883 - $35,323
-220 Reduced 3.38%
6,285 $949,000
Q2 2017

Aug 10, 2017

BUY
N/A
6,505
6,505 $1 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Buckingham Capital Management, Inc. Portfolio

Follow Buckingham Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckingham Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Buckingham Capital Management, Inc. with notifications on news.